MassMutual Private Wealth & Trust’s ImmunityBio IBRX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.29K	Buy	+262	New	+$1.98K	﹤0.01%	1968

Other funds holding IBRX

Pictet Asset Management

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Kercheville Advisors San Antonio, Texas $328M AUM 76.85% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Sheets Smith Wealth Management Winston-Salem, North Carolina $1B AUM 29.77% 1-Year Est. Return

Legacy Capital Group California Los Gatos, California $332M AUM 42.15% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return

NIA Impact Advisors Berkeley, California $241M AUM 44.09% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

MassMutual Private Wealth & Trust's IBRX Position: Q2 2026 in Review

MassMutual Private Wealth & Trust opened a new position in ImmunityBio (IBRX) in Q2 2026: 262 shares worth $2.29K. The stake represents ﹤0.01% of the portfolio and ranks #1968 among its holdings.

141 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

MassMutual Private Wealth & Trust held 262 shares of ImmunityBio worth $2.29K as of Q2 2026.
ImmunityBio was a new MassMutual Private Wealth & Trust position in Q2 2026.
ImmunityBio made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1968 holding.
141 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.